Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31,604,526
-
Total 13F shares
-
39,202,475
-
Share change
-
+376,686
-
Total reported value
-
$1,206,720,767
-
Put/Call ratio
-
683%
-
Price per share
-
$30.78
-
Number of holders
-
190
-
Value change
-
+$15,870,252
-
Number of buys
-
78
-
Number of sells
-
91
Institutional Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q4 2023
As of 31 Dec 2023,
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) was held by
190 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,202,475 shares.
The largest 10 holders included
BlackRock Inc., Rubric Capital Management LP, EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, Pacer Advisors, Inc., PRINCIPAL FINANCIAL GROUP INC, Invesco Ltd., RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, and Camber Capital Management LP.
This page lists
190
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.